IBA FY21 Trading Update

Profitability in all lines of business

Louvain-la-Neuve, Belgium, February 1, 2022 IBA (Ion Beam Applications SA), the global leader in particle accelerator technology, today provides a trading update ahead of the company’s full-year results on March 24, 2022.

The IBA will report group sales for fiscal year 21 in line with the prior year, with positive earnings and net profit at the group level and profitability across all business lines.

  • High amount of orders in all areas of work
    • Proton therapy has seen a sustained recovery in activity with five (nine-chamber) systems sold in Asia, Europe and the United States, compared to two systems sold the previous year
    • Other accelerators had another stellar year with more than 30 systems sold, compared to 17 last year.
    • The dosimetry business continued to perform well with applications being accepted in line with the previous year
  • Backlog in equipment and services at a new all-time high of €1.2 billion
  • A very active pipeline, particularly in the US and Asia, with continued momentum that provides great vision for 2022 and beyond
  • High cash position of €130.3 million (unaudited) at the end of the year, providing the company with a solid foundation for progress on its strategic objectives

Olivier Legrain, CEO of IBA, comment: “IBA performed exceptionally well in 2021, with high order intake and profitability across all business areas. IBA’s market-leading product offerings in proton therapy and other accelerators, radiopharmaceuticals and dosimetry drove this momentum that continued to grow throughout the year. We have We entered 2022 in strong shape with an active global pipeline for all businesses, particularly in the US and Asia.Our record high cash position provides us with a solid foundation on which we can explore other growth areas such as psychology, while achieving our goal of sustainable long-term profitability. the long “.

The IBA will publish its consolidated results for the entire year of 2021 on Thursday, March 24, 2022 at 7 AM CET.

In addition to the press release, Olivier Legrain, CEO, and Suma Chandramouli, Chief Financial Officer, will host a conference call and webcast, conducted in English, to present the full year 2021 results, followed by a question-and-answer session.

Conference call information
This conference call will take place on Thursday, March 24, 2022 at 3PM CET / 2PM GMT / 10AM EST / 7AM PDT as a webinar for teams and can be accessed Online at this link.
If you would like to join by phone only, please call (teleconference ID #913259995):

Belgium: +32 2890 97 20
United Kingdom: +44 20 3321 5200
NL: +31 20708 6901
LU: +352 27 87 00 02
United States: +1 347-991-7591
FR: +33 1 70 99 53 51

Offer will be available at Investor Relations at IBA website and at:
https://www.iba-worldwide.com/content/iba-full-year-2021-results-press-release-and-web-conference Shortly before the call.

To ensure timely communication, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

For participants who do not have the Teams app installed, please follow the process described in this link To get to the conference.

Shareholders’ agenda
Full year results March 24, 2022
Business Update First Quarter 2022 May 19, 2022
General Assembly June 8, 2022
Half-year results on August 31, 2022
Business Update Third Quarter 2022 November 17 2022

*** finish ***

About IBA
IBA (Ion Beam Applications SA) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, which is the most advanced form of radiotherapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals, and dosimetry. The company, headquartered in Louvain-la-Neuve, Belgium, employs nearly 1,500 people worldwide. IBA is a certified B Corporation (B Corp) that meets the highest standards of certified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

Contacts

Sumaya chandermolly
Financial Director
+32 10475890
[email protected]

Olivier Lichen
Corporate Communications Manager
+32 10475890
[email protected]

Strategic Communications Council
Amber Fennell, Angela Gray, Lucy Featherstone
+44 (0) 20 3709 5700
[email protected]

  • 220201-IBA_2021_Trading_Update-EN

.

Leave a Comment